Request a Quote |

Solvay selects Cloe Screen™ for early drug discovery support

Cyprotex (LSE: CRX) today announces it has entered into a new agreement with the pharmaceutical division of Belgian-based Solvay, the international chemicals and pharmaceuticals group, to provide drug discovery support using its Cloe Screen™ technology.

Under the agreement, Cyprotex will screen compounds for Solvay Pharmaceuticals GMBH and Solvay Pharmaceuticals B.V., and provide valuable information on their absorption, distribution, metabolism and excretion (ADME) properties. This information will be used by Solvay Pharmaceuticals to prioritise the best compounds to promote through their discovery process and to guide drug design process in order to maximise the chances of producing a successful drug.

Solvay Pharmaceuticals selected Cyprotex to perform this work after they were satisfied that Cloe Screen™ could consistently deliver high quality data within rapid turnaround times following a series of evaluations.

Dieter Ziegler, Research Program Manager at Solvay, said "We have enjoyed working with the Cyprotex team who have impressed us with quality data coupled with personal observations from their principal scientists regarding our compounds which we find extremely helpful. "

Commenting on the agreement, Robert Morrisson Atwater, CEO of Cyprotex plc, said: "It is exciting to see that Cyprotex's services are being adopted by a wide range of biotechnology and pharmaceutical companies. Yet again, we have passed the very stringent quality criteria that our customers demand, and I am delighted that Solvay, an exciting international pharmaceutical company, has recognised the value Cyprotex can bring to their drug discovery programs."

For further information:

Robert Morrisson Atwater, Chief Executive Officer
Cyprotex plc

Tel: +44 (0) 1625 505100

Henry Harrison-Topham / Heather Salmond
Bankside Consultants Limited
Tel: +44 (0) 20 7444 4140

Contact us

News categories


Contact us to discuss your ADME Tox issues or request a quote

North America (East Coast): +1-888-297-7683
Europe: +44 (0)1625 5051000


or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

By clicking on ‘Send’ I agree that my data is being transferred and used by Cyprotex and the affiliated Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our privacy policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below: